Documents similaires: 50 Years of Immunization—Steps Forward
- Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
- mLife
- ImmunoMedicine
- Global Health Research and Policy
- Dynamical Models of Biology and Medicine
- Public Health Challenges
- BMC Medicine
- Integrative Multi-Omics in Biomedical Research
- BMC Public Health
- International Journal of One Health
- Journal of the International AIDS Society
- npj Health Systems
- Health Care Science
- BJPsych International
- Jurnal Ilmiah Kesehatan Sandi Husada
- GeoHealth
- Tobacco Prevention and Cessation
- Health Economics, Policy and Law
- Annals of Global Health
- Global Challenges
- Clinovate: Advances in Medicine and Healthcare
- Health Expectations
- Acta Universitatis Danubius: Administratio
- Gazeta Médica
Sujet: non-COVID-19 vaccine
- Sujet: South Kivu
- Sujet: immunization
- Sujet: vaccine misinformation
- Sujet: vaccine reactogenicity
- Sujet: adverse reactions
- Sujet: adverse events following immunization
- Sujet: vaccine injury compensation program
- Sujet: cholera
- Sujet: oral cholera vaccine
- Sujet: vaccination campaign
- Sujet: cost
- Sujet: cost-effectiveness
- Sujet: integration
- Sujet: vaccination
- Sujet: service delivery
- Sujet: systematic review
- Sujet: maternal and child health
- Sujet: infant
- Sujet: HIV
- Sujet: malaria
- Sujet: family planning
- Sujet: poliomyelitis
- Sujet: epidemiology
- Sujet: vaccine coverage
- Sujet: surveillance
- Sujet: polio eradication
- Sujet: pertussis
- Sujet: vaccines
- Sujet: diagnosis
- Sujet: vaccine security
- Sujet: global OPV stockpile
- Sujet: immunization policy
- Sujet: inactivated poliovirus vaccine (IPV)
- Sujet: oral poliovirus vaccine (OPV)
- Sujet: vaccine production and distribution
- Sujet: global health security
- Sujet: poliovirus containment
- Sujet: vaccine
- Sujet: microplanning
- Sujet: microplan
- Sujet: LMIC
- Sujet: routine childhood vaccines
- Sujet: newcomer
- Sujet: immunizations
- Sujet: access
- Sujet: equity
- Sujet: qualitative methods
- Sujet: Strategic Advisory Group of Experts (SAGE) on Immunization
- Sujet: SAGE
- Sujet: World Health Organization advisory group
- Sujet: global immunization policy
- Sujet: immunization strategy
- Sujet: vaccination policy
- Sujet: vaccination recommendations
- Sujet: vaccine hesitancy
- Sujet: cancer
- Sujet: pediatric
- Sujet: immunocompromised
- Sujet: public health
- Sujet: influenza
- Sujet: COVID-19
- Sujet: respiratory syncytial virus
- Sujet: outbreaks
- Sujet: maternal vaccination
- Sujet: vaccination week in the Americas
- Sujet: pandemic preparedness and response
- Sujet: life-course immunization
- Sujet: coverage increase
- Sujet: zero-dose
- Sujet: LMICs
- Sujet: hepatitis E
- Sujet: HEV 239
- Sujet: shorter schedule
- Sujet: immunogenicity
- Sujet: efficacy
- Sujet: zero dose
- Sujet: under-five vaccination
- Sujet: human centered design
- Sujet: advocacy
- Sujet: community-centric intervention
- Sujet: National Immunization Technical Advisory Groups
- Sujet: NITAGs
- Sujet: WHO–UNICEF Joint Reporting Form
- Sujet: measles
- Sujet: under-immunized
- Sujet: vaccine inequity
- Sujet: herpes zoster
- Sujet: varicella zoster virus
- Sujet: health policy
- Sujet: Central Africa
- Sujet: big catch-up
- Sujet: peer learning
- Sujet: measles, mumps, and rubella
- Sujet: MMR
- Sujet: Denmark
- Sujet: school
- Sujet: healthcare
- Sujet: education
- Sujet: economic outcomes
- Sujet: HPV vaccination
- Sujet: girls
- Sujet: supplementary immunization activities
- Sujet: coverage
- Sujet: disparities
- Sujet: Togo
- Sujet: immunization equity
- Sujet: children with disabilities
- Sujet: low- and middle-income countries
- Sujet: vaccine barriers
- Sujet: vaccination strategies
- Sujet: inclusive healthcare
- Sujet: adult
- Sujet: health workers
- Sujet: pregnant women
- Sujet: elderly
- Sujet: chronic diseases
- Sujet: Shigella
- Sujet: children
- Sujet: phase III study
- Sujet: endpoints
- Sujet: safety
- Sujet: dengue
- Sujet: Qdenga
- Sujet: CYD-TDV
- Sujet: TAK-003
- Sujet: Wolbachia
- Sujet: antibody-dependent enhancement
- Sujet: mRNA vaccines
- Sujet: school-based programs
- Sujet: n/a
- Sujet: thema EDItEUR::M Medicine and Nursing
Sujet: Vibrio cholerae
- Sujet: South Kivu
- Sujet: immunization
- Sujet: vaccine misinformation
- Sujet: vaccine reactogenicity
- Sujet: adverse reactions
- Sujet: adverse events following immunization
- Sujet: vaccine injury compensation program
- Sujet: cholera
- Sujet: oral cholera vaccine
- Sujet: vaccination campaign
- Sujet: cost
- Sujet: cost-effectiveness
- Sujet: integration
- Sujet: vaccination
- Sujet: service delivery
- Sujet: systematic review
- Sujet: maternal and child health
- Sujet: infant
- Sujet: HIV
- Sujet: malaria
- Sujet: family planning
- Sujet: poliomyelitis
- Sujet: epidemiology
- Sujet: vaccine coverage
- Sujet: surveillance
- Sujet: polio eradication
- Sujet: pertussis
- Sujet: vaccines
- Sujet: diagnosis
- Sujet: vaccine security
- Sujet: global OPV stockpile
- Sujet: immunization policy
- Sujet: inactivated poliovirus vaccine (IPV)
- Sujet: oral poliovirus vaccine (OPV)
- Sujet: vaccine production and distribution
- Sujet: global health security
- Sujet: poliovirus containment
- Sujet: vaccine
- Sujet: microplanning
- Sujet: microplan
- Sujet: LMIC
- Sujet: routine childhood vaccines
- Sujet: newcomer
- Sujet: immunizations
- Sujet: access
- Sujet: equity
- Sujet: qualitative methods
- Sujet: Strategic Advisory Group of Experts (SAGE) on Immunization
- Sujet: SAGE
- Sujet: World Health Organization advisory group
- Sujet: global immunization policy
- Sujet: immunization strategy
- Sujet: vaccination policy
- Sujet: vaccination recommendations
- Sujet: vaccine hesitancy
- Sujet: cancer
- Sujet: pediatric
- Sujet: immunocompromised
- Sujet: public health
- Sujet: influenza
- Sujet: COVID-19
- Sujet: respiratory syncytial virus
- Sujet: outbreaks
- Sujet: maternal vaccination
- Sujet: vaccination week in the Americas
- Sujet: pandemic preparedness and response
- Sujet: life-course immunization
- Sujet: coverage increase
- Sujet: zero-dose
- Sujet: LMICs
- Sujet: hepatitis E
- Sujet: HEV 239
- Sujet: shorter schedule
- Sujet: immunogenicity
- Sujet: efficacy
- Sujet: zero dose
- Sujet: under-five vaccination
- Sujet: human centered design
- Sujet: advocacy
- Sujet: community-centric intervention
- Sujet: National Immunization Technical Advisory Groups
- Sujet: NITAGs
- Sujet: WHO–UNICEF Joint Reporting Form
- Sujet: measles
- Sujet: under-immunized
- Sujet: vaccine inequity
- Sujet: herpes zoster
- Sujet: varicella zoster virus
- Sujet: health policy
- Sujet: Central Africa
- Sujet: big catch-up
- Sujet: peer learning
- Sujet: measles, mumps, and rubella
- Sujet: MMR
- Sujet: Denmark
- Sujet: school
- Sujet: healthcare
- Sujet: education
- Sujet: economic outcomes
- Sujet: HPV vaccination
- Sujet: girls
- Sujet: supplementary immunization activities
- Sujet: coverage
- Sujet: disparities
- Sujet: Togo
- Sujet: immunization equity
- Sujet: children with disabilities
- Sujet: low- and middle-income countries
- Sujet: vaccine barriers
- Sujet: vaccination strategies
- Sujet: inclusive healthcare
- Sujet: adult
- Sujet: health workers
- Sujet: pregnant women
- Sujet: elderly
- Sujet: chronic diseases
- Sujet: Shigella
- Sujet: children
- Sujet: phase III study
- Sujet: endpoints
- Sujet: safety
- Sujet: dengue
- Sujet: Qdenga
- Sujet: CYD-TDV
- Sujet: TAK-003
- Sujet: Wolbachia
- Sujet: antibody-dependent enhancement
- Sujet: mRNA vaccines
- Sujet: school-based programs
- Sujet: n/a
- Sujet: thema EDItEUR::M Medicine and Nursing